Detalhe da pesquisa
1.
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
Cell;
2024 May 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38761800
2.
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
Cell;
184(12): 3205-3221.e24, 2021 06 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34015271
3.
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.
Cell;
163(4): 988-98, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26544943
4.
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
N Engl J Med;
387(14): 1279-1291, 2022 10 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36112399
5.
Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors.
Blood;
142(2): 202-209, 2023 07 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37172200
6.
Interim report of the reactogenicity and immunogenicity of SARS-CoV-2 XBB-containing vaccines.
J Infect Dis;
2024 Feb 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38349280
7.
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis;
2024 Apr 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38598658
8.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
N Engl J Med;
385(19): 1774-1785, 2021 Nov 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34551225
9.
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med;
384(5): 403-416, 2021 02 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33378609
10.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
N Engl J Med;
384(11): 1003-1014, 2021 03 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33730454
11.
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study.
Ann Intern Med;
176(1): 77-84, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36508742
12.
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
J Infect Dis;
227(8): 939-950, 2023 04 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36348617
13.
Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.
J Infect Dis;
2023 Oct 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37795976
14.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis;
228(12): 1662-1666, 2023 12 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37561027
15.
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials.
Clin Infect Dis;
76(2): 271-280, 2023 01 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36130187
16.
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.
Clin Infect Dis;
76(11): 2018-2024, 2023 06 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36740590
17.
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.
Clin Infect Dis;
77(12): 1635-1643, 2023 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37435958
18.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis;
77(4): 560-564, 2023 08 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37036397
19.
Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome.
Am J Respir Crit Care Med;
206(7): 857-873, 2022 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35671465
20.
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial.
Ann Intern Med;
175(9): 1258-1265, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35785530